Browsing Tag
Morgan Stanley
140 posts
Opendoor Technologies (OPEN) targets breakeven as iBuying 2.0 reshapes its business model
Opendoor Technologies (OPEN) is approaching its Q1 2026 earnings test with new products, a Doma acquisition and a breakeven target. Here is the full retail investor breakdown.
From selling stakes to buying them back: What Intel’s $14.2bn move says about its turnaround
Intel pays $14.2bn to buy back Apollo's 49% stake in its Ireland Fab 34. Here's what the deal means for Intel's foundry strategy, balance sheet, and INTC stock. Read more.
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Rivian (RIVN) R2 launch and Uber robotaxi deal put 2026 at the centre of the EV turnaround story
Rivian (NASDAQ: RIVN) is launching the R2 SUV, closing a USD 1.25B Uber robotaxi deal, and receiving fresh VW funding. Here is what retail investors need to know.
Why SpaceX’s reported $2tn IPO target could reset expectations for global capital markets
Bloomberg says SpaceX is targeting a $2 trillion-plus IPO valuation. Read what it could mean for markets, rivals, and the future of mega listings.
Unilever to combine Foods business with McCormick in $44.8bn deal to create global flavour powerhouse
Unilever to sell its $44.8bn Foods business to McCormick in a Reverse Morris Trust deal. Read what this means for ULVR shareholders and MKC's leverage.
IBM and ElevenLabs bring enterprise-grade voice AI to watsonx Orchestrate, targeting regulated sectors at scale
IBM integrates ElevenLabs voice AI into watsonx Orchestrate with HIPAA and PCI controls, targeting healthcare, banking, and government. Read the full analysis.
Can Core Scientific turn bank financing into an AI infrastructure advantage before rivals catch up? (NASDAQ: CORZ)
Core Scientific secures $1B financing to expand AI data center capacity. Read how this funding could reshape growth, competition, and investor outlook.
PBR stock hits 52-week high after Petrobras reports R$ 200bn operating cash flow in 2025
Petrobras (PBR) reports R$ 110bn 2025 net profit, US$ 20bn capex, and record 2.99M boed production. Read the full analysis.
A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq
MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market.